**Aim:** Respiratory viruses are very often detected in pneumonia thanks to uniplex and multiplex real-time PCR techniques. Moreover viruses that are not primilarly the cause of respiratory infections may also be detected such as HSV 1-2, varicella zoster virus and cytomegalovirus.

The aim of our study was to analyze the prevalence of other respiratory infections among broncho-alveolar lavages (BAL) positive for HSV 1-2. The clinical outcome of patients according to the anti HSV 1-2 treatment was also analyzed.

**Material and methods:** Data from hospitalized patients suffering from serious respiratory symptoms and whose broncho-alveolar lavages were positive for HSV 1-2 by an in-house real-time PCR were analyzed.

Nucleic acids (NA) had been extracted with the MagNA Pure 96 DNA and Viral NA Small Volume kit^®^ on the MagNA Pure 96™ instrument (Roche Molecular Diagnostics, Meylan, France).

Samples had been tested for 16 respiratory viruses (influenza A and B, parainfluenza 1--4, respiratory syncytial viruses A and B, human metapneumovirus, coronaviruses 229E, OC43 and NL63, rhinoviruses, enteroviruses, bocaviruses and adenoviruses) with a multiplex RT-PCR (Anyplex™ II RV16 Detection^®^, Seegene) on the CFX96™ Real-Time System (Biorad diagnostics).

NA had also been tested for cytomegalovirus, varicella zoster virus employing a monoplex in-house PCR on the Light Cycler or the Light Cycler 480™ (Roche Molecular Diagnostics, Meylan, France).

Data were analyzed on StataTM software (StataCorp, Texas) using the exact Fisher test.

**Results:** Between 2011 and 2015, 122 (73 males) patients attending an intensive care unit in the Toulouse University Hospital were selected with a HSV 1-2 positive result (mean age 62; 24--86). 119 samples were HSV-1 and three were HSV-2.

117 had been tested with the Anyplex™ II RV16 Detection Seegene^®^. All the viruses of the panel had been detected except parainfluenza 1, 2 and 4, human metapneumovirus and bocavirus; Influenza viruses were the most detected (*n*  = 13), followed by rhinovirus (*n*  = 6), respiratory syncytial virus (*n*  = 5) and adenovirus (*n*  = 4). 117 samples had been tested for cytomegalovirus (26 positive), and 90 for varicella zoster virus (negative).

28 among the 78 samples that tested positive for HSV 1-2 during the winter season (November to April) were also positive for another respiratory virus. During the summer season (May to October) 44 samples tested positive for HSV 1-2 with only 4 in coinfection (*p*  \< 0.005).

The mortality rate did not differ between the HSV 1-2 positive patients treated with acyclovir or valacyclovir (*n*  = 57) and those who were not (*p*  = ns).

**Conclusions:** Our results indicate that HSV 1-2 infection is frequent among patients hospitalized in intensive care unit. During the winter season this infection is linked to other respiratory viruses.

The apparent clinical inefficiency of anti HSV 1-2 treatment indicates that the presence of the virus is more a witness of a clinically poor condition rather than a cause of it.
